PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.35 +0.01 (+2.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

PharmaCyte Biotech (PMCB) Share-based Compensation (IS) (2011 - 2013)

Updated

PharmaCyte Biotech (PMCB) recorded Share-based Compensation (IS) of $1.2 million in fiscal Q1 2014 (quarter ended Jul 31, 2013), up 563.5% from $181,181 a year earlier and up 77.1% from the prior quarter.

Analysis

PharmaCyte Biotech (PMCB) Share-based Compensation (IS) (2011 - 2013) Analysis & Trends

For FY2013 (ended Apr 30, 2013), PharmaCyte Biotech reported Share-based Compensation (IS) of $678,707, down 41.5% from FY2012.

  • Across earlier fiscal years, Share-based Compensation (IS) came in at $1.16 million in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 PharmaCyte Biotech 3.76 Mn -69.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2013 1.20 Mn
Apr 30, 2013 678,707.00
Jul 31, 2012 181,181.00
Apr 30, 2012 136,075.00
Jan 31, 2012 396,476.00
Oct 31, 2011 322,765.00
Jul 31, 2011 305,564.00
API Access

PharmaCyte Biotech Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=PMCB&period=max&api_key=YOUR_API_KEY